DK3737684T3 - 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-on-derivater og relaterede forbindelser som c5a-receptormodulatorer til behandling af vaskulitis og inflammatoriske sygdomme - Google Patents
2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-on-derivater og relaterede forbindelser som c5a-receptormodulatorer til behandling af vaskulitis og inflammatoriske sygdomme Download PDFInfo
- Publication number
- DK3737684T3 DK3737684T3 DK19700269.4T DK19700269T DK3737684T3 DK 3737684 T3 DK3737684 T3 DK 3737684T3 DK 19700269 T DK19700269 T DK 19700269T DK 3737684 T3 DK3737684 T3 DK 3737684T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrazolo
- vasculitis
- pyrimidin
- tetrahydro
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
- Eye Examination Apparatus (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP2018050598 | 2018-01-10 | ||
PCT/EP2019/050372 WO2019137927A1 (en) | 2018-01-10 | 2019-01-09 | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3737684T3 true DK3737684T3 (da) | 2022-12-12 |
Family
ID=65012016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK19700269.4T DK3737684T3 (da) | 2018-01-10 | 2019-01-09 | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-on-derivater og relaterede forbindelser som c5a-receptormodulatorer til behandling af vaskulitis og inflammatoriske sygdomme |
Country Status (29)
Country | Link |
---|---|
US (2) | US11608341B2 (da) |
EP (1) | EP3737684B1 (da) |
JP (1) | JP7014914B2 (da) |
KR (1) | KR102574564B1 (da) |
CN (1) | CN111566109B (da) |
AR (1) | AR114564A1 (da) |
AU (1) | AU2019207666B2 (da) |
BR (1) | BR112020013788A2 (da) |
CA (1) | CA3086310C (da) |
CL (1) | CL2020001817A1 (da) |
DK (1) | DK3737684T3 (da) |
EA (1) | EA202091641A1 (da) |
ES (1) | ES2933820T3 (da) |
HR (1) | HRP20221449T1 (da) |
HU (1) | HUE060515T2 (da) |
IL (1) | IL275868B2 (da) |
LT (1) | LT3737684T (da) |
MA (1) | MA51558B1 (da) |
MX (1) | MX2020007443A (da) |
PH (1) | PH12020500583A1 (da) |
PL (1) | PL3737684T3 (da) |
PT (1) | PT3737684T (da) |
RS (1) | RS63806B1 (da) |
SG (1) | SG11202006490YA (da) |
SI (1) | SI3737684T1 (da) |
TW (2) | TWI839788B (da) |
UA (1) | UA124694C2 (da) |
WO (1) | WO2019137927A1 (da) |
ZA (1) | ZA202004910B (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE060515T2 (hu) * | 2018-01-10 | 2023-03-28 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-Tetrahidro-pirazolo[4,3-d]pirimidin-5-on származékok és rokon vegyületek mint C5A receptor modulátorok vasculitis és gyulladásos betegségek kezelésére |
EP3740476A1 (en) * | 2018-01-19 | 2020-11-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
US11685729B2 (en) | 2018-01-19 | 2023-06-27 | Idorsia Pharmaceuticals Ltd. | C5a receptor modulators |
US20220265658A1 (en) * | 2019-07-09 | 2022-08-25 | Idorsia Pharmaceuticals Ltd. | Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound |
US11193891B2 (en) * | 2019-12-20 | 2021-12-07 | Robert Bosch Gmbh | Receptors and spacers for a fluorescence-based lead ion chemosensor |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003218374A1 (en) * | 2002-03-28 | 2003-10-13 | Neurogen Corporation | Substituted tetrahydroisoquinolines as c5a receptor modulators |
WO2004033455A2 (en) * | 2002-10-08 | 2004-04-22 | Novo Nordisk A/S | Hemisuccinate salts of heterocyclic dpp-iv inhibitors |
US7906528B2 (en) * | 2004-10-05 | 2011-03-15 | Novartis International Pharmaceutical Ltd. | Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
RS56332B1 (sr) * | 2010-06-24 | 2017-12-29 | Chemocentryx Inc | Antagonisti c5ar |
US8846656B2 (en) * | 2011-07-22 | 2014-09-30 | Novartis Ag | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators |
TW202214254A (zh) * | 2013-03-01 | 2022-04-16 | 美商英塞特控股公司 | 吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途 |
ES2642074T3 (es) | 2013-09-04 | 2017-11-15 | Bristol-Myers Squibb Company | Compuestos útiles como inmunomoduladores |
ES2788848T3 (es) | 2013-09-06 | 2020-10-23 | Aurigene Discovery Tech Ltd | Derivados de 1,2,4-oxadiazol como inmunomoduladores |
WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
SI3194401T1 (sl) * | 2014-09-16 | 2020-12-31 | Gilead Sciences, Inc. | Trdne oblike modulatorja toličnega receptorja |
WO2017034872A1 (en) * | 2015-08-25 | 2017-03-02 | Janssen Pharmaceutica Nv | Indazole derivatives useful as cb-1 inverse agonists |
HUE060515T2 (hu) * | 2018-01-10 | 2023-03-28 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-Tetrahidro-pirazolo[4,3-d]pirimidin-5-on származékok és rokon vegyületek mint C5A receptor modulátorok vasculitis és gyulladásos betegségek kezelésére |
EP3740476A1 (en) | 2018-01-19 | 2020-11-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
US11685729B2 (en) | 2018-01-19 | 2023-06-27 | Idorsia Pharmaceuticals Ltd. | C5a receptor modulators |
US20220265658A1 (en) | 2019-07-09 | 2022-08-25 | Idorsia Pharmaceuticals Ltd. | Pharmaceutical composition comprising a tetrahydropyrazolopyrimidinone compound |
-
2019
- 2019-01-09 HU HUE19700269A patent/HUE060515T2/hu unknown
- 2019-01-09 PL PL19700269.4T patent/PL3737684T3/pl unknown
- 2019-01-09 DK DK19700269.4T patent/DK3737684T3/da active
- 2019-01-09 CN CN201980007596.9A patent/CN111566109B/zh active Active
- 2019-01-09 LT LTEPPCT/EP2019/050372T patent/LT3737684T/lt unknown
- 2019-01-09 TW TW111127843A patent/TWI839788B/zh active
- 2019-01-09 PT PT197002694T patent/PT3737684T/pt unknown
- 2019-01-09 HR HRP20221449TT patent/HRP20221449T1/hr unknown
- 2019-01-09 EA EA202091641A patent/EA202091641A1/ru unknown
- 2019-01-09 UA UAA202004963A patent/UA124694C2/uk unknown
- 2019-01-09 SG SG11202006490YA patent/SG11202006490YA/en unknown
- 2019-01-09 SI SI201930400T patent/SI3737684T1/sl unknown
- 2019-01-09 ES ES19700269T patent/ES2933820T3/es active Active
- 2019-01-09 US US16/961,600 patent/US11608341B2/en active Active
- 2019-01-09 KR KR1020207022343A patent/KR102574564B1/ko active IP Right Grant
- 2019-01-09 AU AU2019207666A patent/AU2019207666B2/en active Active
- 2019-01-09 CA CA3086310A patent/CA3086310C/en active Active
- 2019-01-09 RS RS20221138A patent/RS63806B1/sr unknown
- 2019-01-09 MX MX2020007443A patent/MX2020007443A/es unknown
- 2019-01-09 AR ARP190100043A patent/AR114564A1/es unknown
- 2019-01-09 MA MA51558A patent/MA51558B1/fr unknown
- 2019-01-09 TW TW108100804A patent/TWI774905B/zh active
- 2019-01-09 JP JP2020538035A patent/JP7014914B2/ja active Active
- 2019-01-09 BR BR112020013788-0A patent/BR112020013788A2/pt unknown
- 2019-01-09 EP EP19700269.4A patent/EP3737684B1/en active Active
- 2019-01-09 WO PCT/EP2019/050372 patent/WO2019137927A1/en unknown
-
2020
- 2020-07-06 IL IL275868A patent/IL275868B2/en unknown
- 2020-07-07 PH PH12020500583A patent/PH12020500583A1/en unknown
- 2020-07-08 CL CL2020001817A patent/CL2020001817A1/es unknown
- 2020-08-07 ZA ZA2020/04910A patent/ZA202004910B/en unknown
-
2022
- 2022-12-20 US US18/084,911 patent/US20230192708A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3737684T3 (da) | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-on-derivater og relaterede forbindelser som c5a-receptormodulatorer til behandling af vaskulitis og inflammatoriske sygdomme | |
EP3582784A4 (en) | PROCESS FOR THE PREPARATION OF BENZODIAZEPINE DERIVATIVES | |
DK3880676T3 (da) | 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer | |
DK3697784T3 (da) | Imidazo[4,5-b]pyridinforbindelser og farmaceutiske sammensætninger deraf til behandling af inflammatoriske forstyrrelser | |
DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
DK3478679T3 (da) | 5,7-dihydro-pyrrolo-pyridin-derivater til behandling af neurologiske og neurodegenerative sygdomme | |
DK3380471T3 (da) | Tetrahydro-8h-pyrido[1,2-a]pyrazin-8-oner som comt-inhibitorer til behandlingen af neurodegenerative lidelser | |
DK3348557T3 (da) | Imidazo[1,2-a]pyridiner til behandling eller forebyggelse af hyperurekæmi eller gigt | |
DK3524609T3 (da) | Fremgangsmåde til fremstilling af 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromenderivater, optiske isomerer deraf og mellemprodukter fra processen | |
DK3500571T3 (da) | Imidazo[1,2-a]pyridinforbindelser, sammensætninger omfattende disse, fremgangsmåder til behandling af sygdomme ved hjælp af disse og fremgangsmåder til fremstilling heraf | |
DK3535263T3 (da) | Substituerede pyrido[3,4-b]indoler til behandling af bruskforstyrrelser | |
EP3250572A4 (en) | Substituted imidazo [1, 2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof | |
DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
DK3573948T3 (da) | Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater | |
DK3218382T3 (da) | 2,3-dihydro-thiazolo[3,2-a]pyridin-5-on derivativer som antibiotika til behandling af klamydiainfektioner | |
EP3454897A4 (en) | BICYCLIC CONDENSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RSV | |
DK4028017T3 (da) | 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepinderivater og beslægtede forbindelser som lrrk2-, nuak1- og/eller tyk2- kinasemodulatorer til behandling af for eksempel autoimmune sygdomme | |
DK3829579T3 (da) | 1,3,8-triazaspiro-forbindelser og anvendelse deraf som lægemidler til behandling af reperfusionsskader | |
MA53508A (fr) | Cristal de pyrazolo[3,4-d]pyrimidine | |
MA53541A (fr) | Dérivés hétéroaryles bicycliques | |
DK3544630T3 (da) | Ernæringssammensætning med resistent stivelse som er egnet til behandling af neoplastiske sygdomme | |
GB201918444D0 (en) | The integration platform of the community system | |
ES1237400Y (es) | Alcachofa masajeadora para la ducha | |
ZA201902828B (en) | Crystal of pyrido[3, 4-d]pyrimidine derivative or solvate thereof | |
ITUA20163307A1 (it) | Cerotto per il trattamento topico esterno delle patologie articolari |